Delivery Order SPE2DB24D9144-SPE2DB24FCMLQ
Award Date
9/16/24
Potential Completion Date
10/7/24
Potential Value
$41K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $6,848.92 contract is for the delivery of 4,566,869,571 units of Xolair 300 mg/2 ml autoinjector. This delivery order is part of a larger, single-award Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999, which enables the DLA to place orders for a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a Delivery Order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, valued up to $499,999,999, allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The specific award, valued at $9,284.40, is for the supply of XOLAIR 150 MG/ML...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a $3,424.46 firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC). The contract is for the delivery of Xolair 300 mg/2 ml autoinjectors to support the medical supply needs of military healthcare facilities. The IDC, valued at $499,999,999, enables the DLA to issue delivery orders for a wide range of pharmaceutical products, including...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $35,590.20. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division and has no set-aside designation. The contract covers the delivery of Xolair 150mg vials, a specialized injectable biologic medication, to support the recurring medical supply needs of military health facilities...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $3,424.46 for the supply of 4565853377 XOLAIR 300 MG/2 ML AUTOINJECT 2ML. The contract has a firm fixed-price pricing type and an ultimate completion date of October 7, 2024. The award is associated with a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the Defense Logistics Agency (DLA) under the SPE2DB...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $34,244.60, is for the provision of Xolair 300 mg/2 ml autoinjector to the DLA for distribution to various U.S. Department of Defense (DoD) healthcare facilities worldwide. The contract has an ultimate completion date of August 19, 2024. This award is part of...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,683.45 firm fixed-price delivery order is for the supply of Xolair 300 mg/2 ml autoinjectors, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $9,284.40. The contract was awarded by the Defense Logistics Agency (DLA) and has no set-aside designation. It is part of the DLA's larger SPE2DB Indefinite Delivery Contract (IDC) valued at up to $499,999,999, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order with a value of $3,094.80. The award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, and supports the agency's Medical Supply Chain division. The contract is for the delivery of Xolair 150 mg/mL syringes, a specialized pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with the DLA...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $5,136.69 for the supply of the drug Xolair 300 mg/2 ml autoinjector. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 28, 2024. This award is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...